Clinical Trial Update: Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012 [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial of the targeted radiopharmaceutical therapy [131I] ICF01012 for metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• [131I] ICF01012 (ICF01012)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Melanoma | EARLY_Phase 1 | Status: COMPLETED